225 related articles for article (PubMed ID: 10924016)
1. Autoimmune responses against oxidant stress and acetaldehyde-derived epitopes in human alcohol consumers.
Viitala K; Makkonen K; Israel Y; Lehtimäki T; Jaakkola O; Koivula T; Blake JE; Niemelä O
Alcohol Clin Exp Res; 2000 Jul; 24(7):1103-9. PubMed ID: 10924016
[TBL] [Abstract][Full Text] [Related]
2. Serum IgA, IgG, and IgM antibodies directed against acetaldehyde-derived epitopes: relationship to liver disease severity and alcohol consumption.
Viitala K; Israel Y; Blake JE; Niemelä O
Hepatology; 1997 Jun; 25(6):1418-24. PubMed ID: 9185762
[TBL] [Abstract][Full Text] [Related]
3. Detection of circulating antibodies against malondialdehyde-acetaldehyde adducts in patients with alcohol-induced liver disease.
Rolla R; Vay D; Mottaran E; Parodi M; Traverso N; Aricó S; Sartori M; Bellomo G; Klassen LW; Thiele GM; Tuma DJ; Albano E
Hepatology; 2000 Apr; 31(4):878-84. PubMed ID: 10733543
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress as a trigger for cellular immune responses in patients with alcoholic liver disease.
Stewart SF; Vidali M; Day CP; Albano E; Jones DE
Hepatology; 2004 Jan; 39(1):197-203. PubMed ID: 14752838
[TBL] [Abstract][Full Text] [Related]
5. Immune responses against oxidative stress-derived antigens are associated with increased circulating tumor necrosis factor-alpha in heavy drinkers.
Vidali M; Hietala J; Occhino G; Ivaldi A; Sutti S; Niemelä O; Albano E
Free Radic Biol Med; 2008 Aug; 45(3):306-11. PubMed ID: 18460346
[TBL] [Abstract][Full Text] [Related]
6. Immune Responses to Ethanol Metabolites and Cytokine Profiles Differentiate Alcoholics with or without Liver Disease.
Latvala J; Hietala J; Koivisto H; Järvi K; Anttila P; Niemelä O
Am J Gastroenterol; 2005 Jun; 100(6):1303-10. PubMed ID: 15929761
[TBL] [Abstract][Full Text] [Related]
7. IgA immune responses against acetaldehyde adducts and biomarkers of alcohol consumption in patients with IgA glomerulonephritis.
Kaartinen K; Niemelä O; Syrjänen J; Alatalo P; Pörsti I; Harmoinen A; Pasternack A; Huhtala H; Mustonen J
Alcohol Clin Exp Res; 2009 Jul; 33(7):1231-7. PubMed ID: 19389190
[TBL] [Abstract][Full Text] [Related]
8. [Immune response against protein epitopes modified with acetaldehyde and its clinical significance in alcoholic liver diseases].
Yokoyama H
Arukoru Kenkyuto Yakubutsu Ison; 1993 Dec; 28(6):483-96. PubMed ID: 7510476
[TBL] [Abstract][Full Text] [Related]
9. IgAs against acetaldehyde-modified red cell protein as a marker of ethanol consumption in male alcoholic subjects, moderate drinkers, and abstainers.
Hietala J; Koivisto H; Latvala J; Anttila P; Niemelä O
Alcohol Clin Exp Res; 2006 Oct; 30(10):1693-8. PubMed ID: 17010136
[TBL] [Abstract][Full Text] [Related]
10. Interplay between oxidative stress and immunity in the progression of alcohol-mediated liver injury.
Vidali M; Stewart SF; Albano E
Trends Mol Med; 2008 Feb; 14(2):63-71. PubMed ID: 18222109
[TBL] [Abstract][Full Text] [Related]
11. Antibodies against acetaldehyde-modified epitopes: presence in alcoholic, non-alcoholic liver disease and control subjects.
Worrall S; De Jersey J; Shanley BC; Wilce PA
Alcohol Alcohol; 1990; 25(5):509-17. PubMed ID: 1708257
[TBL] [Abstract][Full Text] [Related]
12. Assays for acetaldehyde-derived adducts in blood proteins based on antibodies against acetaldehyde/lipoprotein condensates.
Latvala J; Melkko J; Parkkila S; Järvi K; Makkonen K; Niemelä O
Alcohol Clin Exp Res; 2001 Nov; 25(11):1648-53. PubMed ID: 11707639
[TBL] [Abstract][Full Text] [Related]
13. Valine-alanine manganese superoxide dismutase polymorphism is not associated with alcohol-induced oxidative stress or liver fibrosis.
Stewart SF; Leathart JB; Chen Y; Daly AK; Rolla R; Vay D; Mottaran E; Vidali M; Albano E; Day CP
Hepatology; 2002 Dec; 36(6):1355-60. PubMed ID: 12447859
[TBL] [Abstract][Full Text] [Related]
14. Detection of antibodies to acetaldehyde-albumin conjugates in alcoholic liver disease.
Teare JP; Carmichael AJ; Burnett FR; Rake MO
Alcohol Alcohol; 1993 Jan; 28(1):11-6. PubMed ID: 8471080
[TBL] [Abstract][Full Text] [Related]
15. Acetaldehyde and malondialdehyde react together to generate distinct protein adducts in the liver during long-term ethanol administration.
Tuma DJ; Thiele GM; Xu D; Klassen LW; Sorrell MF
Hepatology; 1996 Apr; 23(4):872-80. PubMed ID: 8666344
[TBL] [Abstract][Full Text] [Related]
16. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
17. Hemoglobin-acetaldehyde adducts in human alcohol abusers.
Niemelä O; Israel Y
Lab Invest; 1992 Aug; 67(2):246-52. PubMed ID: 1380106
[TBL] [Abstract][Full Text] [Related]
18. Conversion of acetaldehyde-protein adduct epitopes from a nonreduced to a reduced phenotype by antigen processing cells.
Klassen LW; Jones BL; Sorrell MF; Tuma DJ; Thiele GM
Alcohol Clin Exp Res; 1999 Apr; 23(4):657-63. PubMed ID: 10235301
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical demonstration of acetaldehyde-modified epitopes in human liver after alcohol consumption.
Niemelä O; Juvonen T; Parkkila S
J Clin Invest; 1991 Apr; 87(4):1367-74. PubMed ID: 1707062
[TBL] [Abstract][Full Text] [Related]
20. Oxidative stress and antioxidant status in patients with alcoholic liver disease.
Masalkar PD; Abhang SA
Clin Chim Acta; 2005 May; 355(1-2):61-5. PubMed ID: 15820479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
